MIRA INFORM REPORT

 

 

Report Date :

28.07.2007

 

IDENTIFICATION DETAILS

 

Name :

CONTINENTAL PHARMACEUTIQUE

 

 

Registered Office :

8 Av Paul Delorme, 76120 Le Grand Quevilly Fr

 

 

Country :

France

 

 

Financials (as on) :

31.12.2005

 

 

Date of Incorporation :

01 January 1972

 

 

Com. Reg. No.:

72B00047

 

 

Legal Form :

Limited Partnership

 

 

Line of Business :

Wholesale of pharmaceutical goods

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

150000 EUR

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

name & address

 

CONTINENTAL PHARMACEUTIQUE

8 AV PAUL DELORME

76120 LE GRAND QUEVILLY FR

Tel. Number       +33-2-32184700

Fax number       +33-2-35724313

 

 

Business founded

01 January 1972

Registration number,

72B00047, ROUEN,

party identification,

582113031,

Legal form

Limited partnership

Activities

Wholesale of pharmaceutical goods

Payment experience

Payment regular

Credit opinion

Normal creditworthiness

 

Maximum credit limit 150000 EUR is advised

 

The export volume in percentage of total sales for the company.  99,64

 

Financial structure (balance sheet analysis) : Balanced 

 

Cash situation (balance sheet analysis) : Sufficient 

 

Profitability (balance sheet analysis) : Good 

 

Commitments (regarding contractual obligations) : Fulfilled („respectés“) 

 

Payment defaults : None 

Employees (Business)

 70

Total number of shareholders

 3

Total share capital31 December 2005

EUR 450000

Bank

CL - BNP - SG 76 ROUEN   

Management

MAZON JEAN-YVES   Shareholder and managing director

 

MOLINATTI PASCAL   Shareholder and managing director

 

BADIN PHILIPPE   Shareholder and managing director

Auditor

DELGADO JOELLE   Deputy auditor

(Part-) Owner

572061281   SOCIETE PHARMACEUTIQUE

ANTILLAISE   10,00 %   

 

387847940   CONTINENTAL PARTICIPATION   10,00 %   

Parent company :

307718577   EURAPHARMA   50,00 %   

Subsidiary company.

OFFICE IMPORT ET DISTRIBUTION

PHARMACEUTIQUE   96,00 %   

Affiliate. A company which is affiliated with the Business.

OFFICE CALEDONIEN DE DISTRIBUTION

PHARMACEUTIQUE   5,00 %   

 

OFFICE POLYSIEN DE DISTRIBUTION

PHARMACEUTIQUE   5,00 %   

 

L'OFFICE CALEDONIEN   5,00 %   

 

 

The business owns or partly owns one or more pieces of land and buildings?  No (Property) 

 

Turnover for the period: 00 0000 - 31 December 2005  in  EUR 176.780.857,00

 Not consolidated profit and loss turnover of the business: 

 

Corporate balance sheet for the year: 00 0000 - 31 December 2005  in  EUR 

Total assets incl. prepaid expenses and accrued income

143.241.784,-

Total fixed assets

809.982,-

Total intangible fixed assets

86.734,-

Concessions and industrial rights, goodwill

86.734,-

Total tangible fixed assets

639.314,-

Plant, machinery and equipment

124.917,-

Total financial fixed assets

83.935,-

Loans, shares and participations

4.163,-

Total Current assets

142.431.803,-

Inventories and work in progress (incl. prepayments)

4.448.083,-

Accounts receivable (trade)

73.862.870,-

Cash in hand and at bank

23.764,-

Total accrued income and prepaid expenses

121.270,-

Total equity, provisions, liabilities, accrued expenses and deferred income

143.241.784,-

Total equity (Shareholders' funds)

14.605.318,-

Issued (subscribed) capital

450.000,-

Profit or loss carried forward

7.544.684,-

Profit or loss for the previous year

8.178.303,-

Profit or loss for the financial year

6.599.505,-

Total provisions

242.073,-

Total liabilities

128.394.394,-

Total long-term liabilities

5.800.267,-

Long-term Loans, Mortgage debts

5.800.266,-

Long-term liabilities to credit institutions

1,-

Total current liabilities

122.594.128,-

Current accounts payable (trade)

112.062.897,-

Income and social tax liabilities

3.669.126,-

Borrowing ratio

869,58 %

Current ratio

116,18 %

Debt gearing

39,28 %

Profit margin.

3,77 %

Quick ratio

112,55 %

Return on assets

4,66 %

Return on equity.

44,70 %

Solidity or equity ratio

10,31 %

 

Corporate profit and loss account for the year: 00 0000 - 31 December 2005  in  EUR 

Total operating income/revenue

177.095.914,-

Main revenue (sales/turnover)

176.780.857,-

Total operating expenses

170.426.859,-

Cost of materials (type of expenditure format)

159.141.482,-

Personnel costs

4.941.634,-

Depreciation

197.038,-

Operating profit or loss

6.669.056,-

Financial income

7.305.752,-

Financial expenses

3.225.131,-

Result of ordinary operations

10.749.677,-

Extraordinary income

59.592,-

Extraordinary expenses

1.813.195,-

Extraordinary result

-1.753.603,-

Pre-tax and pre-appropriation profit or loss

10.749.677,-

Taxes

1.771.569,-

Net profit or loss

6.599.505,-

 

Turnover for the period: 00 0000 - 31 December 2004  in  EUR 165.666.745,00

 Not consolidated profit and loss turnover of the business: 

 

Corporate balance sheet for the year: 00 0000 - 31 December 2004  in  EUR 

Total assets incl. prepaid expenses and accrued income

134.871.665,-

Total fixed assets

596.439,-

Total intangible fixed assets

48.769,-

Concessions and industrial rights, goodwill

48.769,-

Total tangible fixed assets

460.678,-

Plant, machinery and equipment

138,-

Total financial fixed assets

86.991,-

Loans, shares and participations

10.675,-

Total Current assets

134.275.226,-

Inventories and work in progress (incl. prepayments)

3.977.808,-

Accounts receivable (trade)

67.027.422,-

Cash in hand and at bank

175.524,-

Total accrued income and prepaid expenses

176.334,-

Total equity, provisions, liabilities, accrued expenses and deferred income

134.871.665,-

Total equity (Shareholders' funds)

15.565.813,-

Issued (subscribed) capital

450.000,-

Profit or loss carried forward

6.926.381,-

Profit or loss for the previous year

7.074.981,-

Profit or loss for the financial year

8.178.303,-

Total provisions

263.086,-

Total liabilities

119.042.766,-

Total long-term liabilities

11.537.524,-

Long-term Loans, Mortgage debts

11.537.523,-

Long-term liabilities to credit institutions

1,-

Total current liabilities

107.505.242,-

Current accounts payable (trade)

96.243.148,-

Income and social tax liabilities

3.185.012,-

Borrowing ratio

756,33 %

Current ratio

124,90 %

Debt gearing

73,30 %

Profit margin.

5,00 %

Quick ratio

121,20 %

Return on assets

6,14 %

Return on equity.

51,96 %

Solidity or equity ratio

11,67 %

 

Corporate profit and loss account for the year: 00 0000 - 31 December 2004  in  EUR 

Total operating income/revenue

167.709.521,-

Main revenue (sales/turnover)

165.666.745,-

Total operating expenses

159.422.592,-

Cost of materials (type of expenditure format)

148.910.368,-

Personnel costs

4.434.269,-

Depreciation

180.373,-

Operating profit or loss

8.286.929,-

Financial income

7.043.464,-

Financial expenses

3.120.070,-

Result of ordinary operations

12.210.323,-

Extraordinary income

28.558,-

Extraordinary expenses

1.775.879,-

Extraordinary result

-1.747.321,-

Pre-tax and pre-appropriation profit or loss

12.210.323,-

Taxes

1.720.699,-

Net profit or loss

8.178.303,-

 

Turnover for the period: 00 0000 - 31 December 2003  in  EUR 167.011.532,00

 Not consolidated profit and loss turnover of the business: 

 

Corporate balance sheet for the year: 00 0000 - 31 December 2003  in  EUR 

Total assets incl. prepaid expenses and accrued income

124.690.668,-

Total fixed assets

629.990,-

Total intangible fixed assets

27.670,-

Concessions and industrial rights, goodwill

27.670,-

Total tangible fixed assets

517.016,-

Plant, machinery and equipment

160,-

Total financial fixed assets

85.304,-

Loans, shares and participations

10.675,-

Total Current assets

124.060.678,-

Inventories and work in progress (incl. prepayments)

3.985.968,-

Accounts receivable (trade)

64.477.024,-

Investments (short-term)

1,-

Cash in hand and at bank

70.093,-

Total accrued income and prepaid expenses

86.581,-

Total equity, provisions, liabilities, accrued expenses and deferred income

124.690.668,-

Total equity (Shareholders' funds)

14.947.510,-

Issued (subscribed) capital

450.000,-

Profit or loss carried forward

7.411.400,-

Profit or loss for the financial year

7.074.981,-

Total provisions

241.624,-

Total liabilities

109.501.534,-

Total long-term liabilities

14.133.983,-

Long-term Loans, Mortgage debts

14.133.983,-

Total current liabilities

95.367.551,-

Current accounts payable (trade)

86.975.316,-

Income and social tax liabilities

2.880.221,-

Borrowing ratio

724,84 %

Current ratio

130,09 %

Debt gearing

93,56 %

Profit margin.

4,70 %

Quick ratio

125,91 %

Return on assets

6,29 %

Return on equity.

46,83 %

Solidity or equity ratio

12,12 %

 

Corporate profit and loss account for the year: 00 0000 - 31 December 2003  in  EUR 

Total operating income/revenue

167.365.107,-

Main revenue (sales/turnover)

167.011.532,-

Total operating expenses

159.517.389,-

Cost of materials (type of expenditure format)

152.041.921,-

Personnel costs

3.884.510,-

Depreciation

148.159,-

Operating profit or loss

7.847.718,-

Financial income

7.412.044,-

Financial expenses

3.485.179,-

Result of ordinary operations

11.774.584,-

Extraordinary income

86.138,-

Extraordinary expenses

2.364.249,-

Extraordinary result

-2.278.111,-

Pre-tax and pre-appropriation profit or loss

11.774.584,-

Taxes

1.879.492,-

Net profit or loss

7.074.981,-

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions